Brown, Lisle/Cummings’s iShares US Pharmaceuticals ETF IHE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $156K | Buy |
2,376
+129
| +6% | +$8.46K | 0.04% | 235 |
|
|
2025
Q1 | $159K | Hold |
2,247
| – | – | 0.05% | 227 |
|
|
2024
Q4 | $148K | Hold |
2,247
| – | – | 0.04% | 232 |
|
|
2024
Q3 | $159K | Sell |
2,247
-858
| -28% | -$60.6K | 0.05% | 228 |
|
|
2024
Q2 | $206K | Hold |
3,105
| – | – | 0.07% | 196 |
|
|
2024
Q1 | $211K | Hold |
3,105
| – | – | 0.07% | 189 |
|
|
2023
Q4 | $192K | Sell |
3,105
-63
| -2% | -$3.89K | 0.07% | 198 |
|
|
2023
Q3 | $187K | Hold |
3,168
| – | – | 0.08% | 189 |
|
|
2023
Q2 | $189K | Hold |
3,168
| – | – | 0.08% | 184 |
|
|
2023
Q1 | $185K | Hold |
3,168
| – | – | 0.09% | 176 |
|
|
2022
Q4 | $197K | Sell |
3,168
-264
| -8% | -$16.4K | 0.11% | 159 |
|
|
2022
Q3 | $194K | Hold |
3,432
| – | – | 0.11% | 149 |
|
|
2022
Q2 | $219K | Sell |
3,432
-825
| -19% | -$52.7K | 0.12% | 150 |
|
|
2022
Q1 | $276K | Buy |
4,257
+192
| +5% | +$12.4K | 0.13% | 145 |
|
|
2021
Q4 | $270K | Buy |
+4,065
| New | +$270K | 0.14% | 142 |
|